BackBio-Rad Laboratories Overview
Bio-Rad Laboratories Inc. - Ordinary Shares - Class A

Bio-Rad Laboratories Target Price

Analysts' average 12-month price target for Bio-Rad Laboratories is $360.

Get informed when a big investor buys or sells

+ Follow

Share Price

$378

Average Target Price

$356.675.6% downside

3 analysts in the last 4 months

High: $390 | Low: $310

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-08-07RBC Capital$3903.2% upsideOpen
2026-08-05RBC Capital$3702.1% downsideOpen
2026-05-25Wells Fargo$31018% downsideOpen
2026-05-14RBC Capital$32015.3% downsideOpen
2026-05-01Wells Fargo$29023.3% downsideOpen
2026-02-16Wells FargoBrandon Couillard$32015.3% downsideOpen
2026-02-13UBS$33511.4% downsideOpen
2025-10-30Wells Fargo$34010.1% downsideOpen
2024-10-01CitigroupPatrick Donnelly$4005.8% upsideOpen
2022-12-07RBC Capital$56549.5% upsideOpen

Bio-Rad Laboratories (BIO) FAQ

Bio-Rad Laboratories (BIO) currently reports a target price of $360. Use the charts on this page to explore Bio-Rad Laboratories's target price history and peer comparisons.

Analysts' average 12-month price target for Bio-Rad Laboratories is $360, about 5.6% downside from the current share price of $378.0. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.

Start with the current target price of $360, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Bio-Rad Laboratories, and consider following BIO for alerts when major investors trade the stock.

Bio-Rad Laboratories is classified in the Healthcare sector. On target price, it currently shows $360. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing BIO with unrelated industries.